DermTalks Podcast – Atopic Dermatitis in Special Populations

In this episode, Dr. Halvorsen delves into the comorbidities associated with atopic dermatitis. There is a growing interest in this area as AD can be linked to both atopic and non-atopic comorbidities. Furthermore, the presence or risk of comorbidities can significantly impact the management of patients with AD. Sanofi North-Europe, MAT-BE-2401082 – 1.0 – 13-01-2025

In this podcast, Dr. Martta Jokinen delves into the intersection of atopic dermatitis and cancer, focusing specifically on cutaneous T-cell lymphoma also called CTCL and shares her insights on CTCL in the management of patients with atopic dermatitis. Atopic dermatitis and early-stage CTCL share some clinical features, such as red, itchy skin lesions, raising concerns about misdiagnosis. Additionally, while managing AD with advanced therapies, it’s crucial to have a comprehensive understanding of CTCL.Sanofi North-Europe, MAT-BE-2401025 – 1.0 – 12/11/2024

In this episode, Dr. Stine Simonsen delves into the management of atopic dermatitis in elderly patients. AD is common in the elderly and diagnosing it can be challenging due to its varied presentation. When considering treatment, it is also essential to account for the patient’s overall medical condition, current medications, and their general physical and mental health status.Sanofi North-Europe, MAT-BE-2401013 – 1.0 – 12/11/2024

In this episode, Dr. Hannah de Leye shares her insights on the atopic march, food allergies, including IgE testing and restrictive diets, as well as early interventions that may help restore skin barrier function and prevent the progression of atopic diseases.Sanofi North-Europe, MAT-BE-2401229 – 1.0 – 28/01/2025

In this episode, Dr. Klas Agerberg delves into the management of atopic dermatitis during pregnancy and breastfeeding. It’s crucial to approach this patient group with a ‘safety first’ mindset, prioritizing the well-being of both the mother and the developing fetus, as well as balancing the importance of a well-controlled disease.Sanofi North-Europe, MAT-BE-2400986 – 1.0 – 09/01/2025